Dinopol, Danilo F.
HRN: 22-07-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/16/2022
10/23/2022
IV
600mg
Q8H
DM Foot, R
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes